Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

US Patent 8420631 · Granted Apr 16, 2013

Estimated economic value: $124,968,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

KIF18A inhibitors2025
KRAS G12C inhibitors and methods of using the same2025
KIF18A inhibitors2025
KIF18A inhibitors2025
KCNQ potentiators2025
Substituted piperazines as KRAS G12C inhibitors2024
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-2024
KRAS G12C inhibitors and methods of using the same2024
KCNQ potentiators2023
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-2023
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2023
Apelin polypeptides2023